MRK announced a cash dividend of 0.77 with an ex-date of Dec. 14, 2023
|Bid||103.82 x 1300|
|Ask||103.89 x 800|
|Day's Range||102.65 - 104.00|
|52 Week Range||99.14 - 119.65|
|Beta (5Y Monthly)||0.35|
|PE Ratio (TTM)||57.96|
|Earnings Date||Feb 01, 2024|
|Forward Dividend & Yield||3.08 (2.97%)|
|Ex-Dividend Date||Dec 14, 2023|
|1y Target Est||124.90|
Subscribe to Yahoo Finance Plus to view Fair Value for MRK
In this article, we will take a look at the 12 healthcare stocks billionaires like the most. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Healthcare Stocks Billionaires Like the Most. The healthcare sector includes companies ranging from pharmaceuticals, medical equipment and device manufacturers, […]
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
After a late-stage study fails to show any improvement in its primary endpoints, Merck (MRK) decides to stop evaluating the Keytruda-Lynparza combination in metastatic squamous NSCLC.